Neuroleptic Malignant Syndrome: Complications, Outcomes, and Mortality

Neurocritical Care

Volumn 24, Issue 1, 2016, Pages 97-103

  Modi, Sumul ^a   Dharaiya, Devanshi ^a   Schultz, Lonni ^b   Varelas, Panayiotis ^a  

^a HENRY FORD HOSPITAL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Complications; Mortality; Neuroleptic malignant syndrome; Outcome

Indexed keywords

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ACUTE LIVER FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; COMORBIDITY; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLEPTIC MALIGNANT SYNDROME; PHYSICAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOLYSIS; SEIZURE; SEPSIS; UNITED STATES; ACUTE KIDNEY INJURY; COMPLICATION; HEART FAILURE; MIDDLE AGED; OUTCOME ASSESSMENT; RESPIRATORY INSUFFICIENCY; STATISTICS AND NUMERICAL DATA;

ACUTE KIDNEY INJURY; ADULT; AGED; COMORBIDITY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; OUTCOME ASSESSMENT (HEALTH CARE); RESPIRATORY INSUFFICIENCY; RHABDOMYOLYSIS; UNITED STATES;

EID: 84957435907     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-015-0162-5     Document Type: Article

References (19)

1. Delay J, Pichot P, Lemperiere T, Elissalde B, Peigne F. A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses. Ann Med Psychol. 1960;118(1):145–52.
2. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137–45.
3. Caroff SN, Mann SC, Lazarus A, Sullivan K, MacFadden W. Neuroleptic malignant syndrome: diagnostic issues. Psychiatr Ann. 1991;21:130–47.
4. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77:185–202.
5. Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23:477–92.
6. Rosenberg MR, Green M. Neuroleptic malignant syndrome. Review of response to therapy. Arch Intern Med. 1989;149:1927–31.
7. Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry. 1987;22:1004–20.
8. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine. 2005;84:377–85.
9. Taniguchi N, Tanii H, Nishikawa T, et al. Classification system of complications in neuroleptic malignant syndrome. Methods Find Exp Clin Pharmacol. 1997;19:193–9.
10. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J psychiatry. 2007;164:870–6.
11. Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth. 2000;85:129–35.
12. Gibb WR, Lees AJ. The neuroleptic malignant syndrome—a review. Q J Med. 1985;56:421–9.
13. Nakamura M, Yasunaga H, Miyata H, Shimada T, Horiguchi H, Matsuda S. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese diagnosis procedure combination database. J Clin Psychiatry. 2012;73:427–30.
14. Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry. 1989;50:18–25.
15. Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatr. 1980;41:79–83.
16. Shalev A, Munitz H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatr Scand. 1986;73:337–47.
17. Lazarus A. The neuroleptic malignant syndrome: a review. Can J Psychiatry. 1986;31:670–4.
18. Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. New Engl J Med. 1974;291:807–11.
19. Sanai T, Matsui R, Hirano T, et al. Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure. Ren Fail. 2006;28:51–5.